Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T23653 |
Afegostat HCl
Afegostat,AT-2101,Afegostat hydrochloride,AT2101 |
||
Afegostat is an acid β-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone. Afegostat inhibits GCase with K(i) ~30 nM for wild-type and mutant enzymes. Afegostat was an experimental drug for the treatment of certain forms of | |||
T71474 | H-201-70 | ||
H-201-70 is a partial beta1 agonist with adrenoreceptor stimulatory effects. | |||
T28424 |
PKUMDL-WQ-2101
|
Dehydrogenase | Metabolism |
PKUMDL-WQ-2101 是磷酸甘油酸脱氢酶的选择性变构抑制剂,具有抗肿瘤活性。 | |||
TP2101 |
Z-VRPR-FMK trifluoroacetate salt
|
||
Irreversible MALT1 inhibitor. Suppresses T cell activation-induced cleavage of Bcl-10 in a dose-dependent manor. Reduces Jurkat cell adhesion to fibronectin. Cell permeable. |